Come up with a name for your new list and we'll add to it:
Axonyx raised a round of funding on May 11, 2004.
Axonyx is engaged in the business of identifying and acquiring novel post-discovery central nervous system (CNS) drug candidates to advance through clinical development towards regulatory approval. Th…
